Durham-based Quintiles Transnational laid off an undisclosed number of employees Thursday as the company looks for more efficient ways to conduct clinical trials for its customers.
"I can tell you that it's very limited," Quintiles spokesman Phil Bridges said. "It is not limited to this area."
The company did not file a notice under the Worker Adjustment and Retraining Notification Act, something that is required by federal law any time a company is planning to shut down a facility or lay off a large number of workers.
Bridges also said Quintiles continues to hire in many areas. It lists 351 job openings in the United States on its website. It is the largest contract drug research company in the world and has more than 20,000 employees working in 60 countries. About 1,400 are in the Triangle.
State and local officials have promised Quintiles incentives worth up to $25 million over 12 years. Thus far the company has exceeded the requirements of a state incentives package it was awarded in 2006.
The company has invested $51 million in its headquarters in the Imperial Center business park off Interstate 40, which opened last year. The state Job Development Investment Grant requires that it invest $54 million by 2013.
Bridges said that as of the end of 2009, Quintiles has added 453 employees in three years. The state requirement was 116 new jobs.
Late last year, Quintiles, citing the state's revenue shortfall, asked state Commerce officials to delay paying the company $299,000 in incentives until the end of the state's fiscal year in June.
Quintiles was started more than 25 years ago by former UNC-Chapel Hill professor Dennis Gillings. He took the company private in 2003.